1. Adelaide Research & Scholarship
  2. Schools and Disciplines
  3. School of Paediatrics & Reproductive Health
  4. Obstetrics and Gynaecology
  5. Obstetrics and Gynaecology publications
Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/85830
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorvan Meurs, H.-
dc.contributor.authorTajik, P.-
dc.contributor.authorHof, M.-
dc.contributor.authorVergote, I.-
dc.contributor.authorKenter, G.-
dc.contributor.authorMol, B.-
dc.contributor.authorBuist, M.-
dc.contributor.authorBossuyt, P.-
dc.date.issued2013-
dc.identifier.citationEuropean Journal of Cancer, 2013; 49(15):3191-3201-
dc.identifier.issn0959-8049-
dc.identifier.issn1879-0852-
dc.identifier.urihttp://hdl.handle.net/2440/85830-
dc.description.abstractAbstract not available-
dc.description.statementofresponsibilityHannah S. van Meurs, Parvin Tajik, Michel H.P. Hof, Ignace Vergote, Gemma G. Kenter, Ben Willem J. Mol, Marrije R. Buist, Patrick M. Bossuyt-
dc.language.isoen-
dc.publisherElsevier-
dc.rights© 2013 Elsevier Ltd. All rights reserved.-
dc.source.urihttp://dx.doi.org/10.1016/j.ejca.2013.06.013-
dc.subjectOvarian cancer; treatment selection; additive interaction; chemotherapy; surgery-
dc.titleWhich patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial-
dc.typeJournal article-
dc.identifier.doi10.1016/j.ejca.2013.06.013-
pubs.publication-statusPublished-
dc.identifier.orcidMol, B. [0000-0001-8337-550X]-
Appears in Collections:Aurora harvest 2
Obstetrics and Gynaecology publications

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.